Background Posterior reversible encephalopathy syndrome (PRES) is a well-recognized
clinico-neuroradiological transient condition. Early recognition is of paramount importance …

Adrenocorticotropin-secreting pituitary tumor represents about 10% of pituitary adenomas
and at the time of diagnosis most of them are microadenomas. Transsphenoidal surgery is …

In the management of adrenocorticotropic hormone (ACTH)–dependent Cushing's
syndrome, inferior petrosal sinus sampling (IPSS) provides information for the …

Background: The default-mode network (DMN) has been increasingly recognized as
relevant to cognitive status. Objectives: To explore DMN changes in patients with relapsing …

Introduction We report the experiences of 25 Italian centers, analyzing intra-and
periprocedural complications of endovascular treatment of intracranial aneurysms using Silk …

Objective We aimed to investigate the efficacy of pegvisomant in patients with acromegaly
resistant to long-term (≧ 24-month), high-dose treatment with octreotide-LAR (40 mg/month) …

Objective To describe clinical, neuroradiological and evolutionary findings in obstetric
patients with posterior reversible encephalopathy syndrome (PRES). Design Retrospective …

Background: Posterior Reversible Encephalopathy (PRES) is characterizedby acute-onset
headache, altered mental status, cortical blindness and seizures, with parietal …

Context: Primary treatment with depot octreotide and lanreotide induces tumor shrinkage in
newly diagnosed patients with acromegaly. Objective: The objective of the study was to …

Introduction: To determine the occurrence of neuroradiological abnormalities and to perform
genotype–phenotype correlations in severe myoclonic epilepsy of infancy (SMEI, Dravet …